Log In
BCIQ
Print this Print this
 

LTI-02

  Manage Alerts
Collapse Summary General Information
Company Lung Therapeutics Inc.
DescriptionInhaled version of LT-01, a single chain urokinase plasminogen activator
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationAcute lung injury
Indication DetailsTreat acute lung injury
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today